Scope 1, 2, and 3 greenhouse gas (GHG) emissions
The company has an opportunity to disclose reductions in Scope 1 and 2 and Scope 3 greenhouse gas emissions, and set time-bound targets aligned with the Paris Agreement’s 1.5 degree pathway.
Animal welfare
The company has an opportunity to set animal welfare targets applicable to all species, geographies and products.
Antibiotic use and growth promoting substances
The company has an opportunity to disclose targets to phase out the prophylactic use of antibiotics across all species, geographies and products, and report progress against the targets.
Ecosystem conversion
The company has an opportunity to disclose its efforts to avoid ecosystem conversion, including deforestation or restoration. It could develop a strategy and publicly report on specific, time-bound targets.
Food loss and waste
The company has an opportunity to disclose its food loss and waste (FLW) reduction targets and report progress against these targets. Additionally, it can consider aligning its FLW reduction goal with SDG12.3, which aims for a 50% reduction by 2030.
Plastic use and packaging waste
The company has an opportunity to disclose quantitative evidence regarding plastic use reduction and use of sustainable packaging.
Protein diversification
The company has an opportunity to set a sales-based target to increase alternative proteins across its portfolio, as well as report progress against this target.
Water withdrawal
The company has an opportunity to enhance its disclosures relating to water use and withdrawal.